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Public HealthBackground: Vaccination intention is key to the success of any vaccination programme, alongside vaccine
availability and access. Public intention to take a COVID-19 vaccine is high in England andWales compared
to other countries, but vaccination rate disparities between ethnic, social and age groups has led to concern.
Methods: Online survey of prospective household community cohort studyparticipants across England and
Wales (Virus Watch). Vaccination intention was measured by individual participant responses to ‘Would
you accept a COVID-19 vaccine if offered?’, collected in December 2020 and February 2021. Responses to
a 13-item questionnaire collected in January 2021 were analysed using factor analysis to investigate psy-
chological influences on vaccination intention.
Results: Survey response rate was 56% (20,785/36,998) in December 2020 and 53% (20,590/38,727) in
February 2021, with 14,880 adults reporting across both time points. In December 2020, 1,469 (10%) par-
ticipants responded ‘No’ or ‘Unsure’. Of these people, 1,266 (86%) changed theirmindand responded ‘Yes’ or
‘Already had a COVID-19 vaccine’ by February 2021. Vaccination intention increased across all ethnic
groups and levels of social deprivation. Age was most strongly associated with vaccination intention, with
16–24-year-olds more likely to respond ‘‘Unsure” or ‘‘No” versus ‘‘Yes” than 65–74-year-olds in December
2020 (OR: 4.63, 95 %CI: 3.42, 6.27 & OR 7.17 95 %CI: 4.26, 12.07 respectively) and February 2021 (OR: 27.92
95 %CI: 13.79, 56.51 & OR 17.16 95 %CI: 4.12, 71.55). The association between ethnicity and vaccination
T. Byrne, P. Patel, M. Shrotri et al. Vaccine 39 (2021) 7108–7116intention weakened, but did not disappear, over time. Both vaccine- and illness-related psychological fac-
tors were shown to influence vaccination intention.
Conclusions: Four in five adults (86%) who were reluctant or intending to refuse a COVID-19 vaccine in
December 2020 had changed their mind in February 2021 and planned to accept, or had already accepted,
a vaccine.
 2021 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Vaccination intention, which refers to the intention to take or
refuse a vaccine when offered, determines the success of any vac-
cination programme, alongside vaccine availability and access. In
2019, the World Health Organization listed the reluctance or refu-
sal of vaccines as one of the top threats to global public health [1].
Patterns and drivers of vaccination intention have been shown to
vary over time and region, correlating to local politics, history
and religion [2].
The UK’s COVID-19 vaccination programme plans to achieve
high levels of vaccination coverage across the population [3].
Procuring sufficient vaccines and delivering mainly through uni-
versal primary care has meant the UK currently has one of the
highest COVID-19 vaccination rates per capita in the world [4].
Public intention to take a COVID-19 vaccine when offered is high
in the UK [5], but evidence of disparities in vaccination intention
between ethnic and social groups has led to significant concern
among public health practitioners, the National Health Service
(NHS) (which is leading the UK’s vaccine delivery), voluntary sector
organisations, the media and politicians [6–8].
Previous studies have found that age, ethnicity, income and
education are independently associated with COVID-19 vaccina-
tion intention [9,10]. They found young adults, people from most
minority ethnic backgrounds, people on low income and people
with low education levels are more likely to be reluctant or refuse
a COVID-19 vaccine [9,10]. Reluctance or refusal to take a vaccine
is contributing to disparities in COVID-19 vaccination rates, which
is lower in most minority ethnic populations and in areas of higher
deprivation [11,12]. However, it is unclear to what extent dispari-
ties in COVID-19 vaccination rates are a result of differences in vac-
cination intention, as opposed to structural factors that determine
vaccine access, such as capability to travel to a vaccination centre
[13,14].
Research conducted before the UK’s COVID-19 vaccination pro-
gramme commenced found beliefs around the efficacy and safety
of COVID-19 vaccines are likely to be the greatest psychological
influence on vaccination intention [15]. It is not clear if this
remains has remained the case since the vaccination programme
began and if perceptions of the risk of COVID-19 illness also influ-
ences vaccination intention.
Disparities in COVID-19 vaccination rates are especially con-
cerning given the greater risk of COVID-19 infection, severe illness
and death in most minority ethnic populations and areas of high
deprivation [16,17]. Following concerted and targeted action to
increase public intention to take a COVID-19 vaccine, there is a
need to determine whether vaccination intention is changing over
time.
This study aims to:
(1) Examine how COVID-19 vaccination intention has changed
over time, across different populations in England and
Wales.
(2) Investigate socio-demographic factors associated with cur-
rent vaccination intention in England and Wales.7109(3) Investigate how vaccine- and illness-related psychological
factors (attitudes, beliefs and emotions) may influence vac-
cination intention and whether these factors vary across
populations.
2. Methods
2.1. Study design and procedure
Data for this analysis were collected as part of the Virus Watch
study, a large prospective household community cohort study of
the transmission and burden of COVID-19 in England and Wales.
The full study design and methodology has been described else-
where [18]. Data collection using online REDCap surveys began
on 24 June 2020 and is ongoing.
After enrolling in the study, an initial baseline survey collected
demographic, occupation, financial and medical history data from
participants. Thereafter, participants were surveyed weekly (con-
tacted by email) on the presence or absence of symptoms that
could indicate COVID-19 disease, activities undertaken prior to
symptom onset, any SARS-CoV-2 swab test results, and COVID-19
vaccine uptake in the previous week. Bespokemonthly surveys col-
lected detailed information on potential determinants of SARS-
CoV-2 infection and COVID-19 disease.
2.2. Participants
Participants were recruited into the Virus Watch study using a
range of methods including by post, social media, SMS messages or
personalised letters from General Practices with tokens of appreci-
ation for participation. Participants were eligible if all household
members agreed to take part, if they had access to the internet
(Wi-Fi, fixed or on a mobile phone) and an email address. At least
one household member had to be able to read English to complete
the surveys. Participants were not eligible if their household was
larger than 6 people (due to limitations of the online survey
infrastructure).
In the analyses described in this report, we excluded respon-
dents under the age of 16 for two reasons. First, survey responses
are more likely to represent parental views than views of children
themselves as the surveys may be completed by an adult on their
child’s behalf. Second, children were not eligible for vaccination in
the UK at the time of data collection, which may have influenced
parents’ intention to vaccinate their children.
2.3. Exposures
We explored key demographic, social, and clinical variables that
could be associated with COVID-19 vaccination intention amongst
adults. Age (on entry to the study) and sex (at birth) were defined a
priori as variables of interest. Other variables of interest included
self-reported ethnicity, grouped as per the following ONS cate-
gories: ‘White British’, ‘White Irish’, ‘White Other’, ‘South Asian’,
‘Other Asian’, ‘Black’, ‘Mixed’, ‘Other ethnicity’; whether born in
the UK or born abroad; region of residence within England and
Wales; small area-level deprivation using the Indices of Multiple
T. Byrne, P. Patel, M. Shrotri et al. Vaccine 39 (2021) 7108–7116Deprivation (IMD) based on postcode of residence [19]; presence of
comorbidities associated with higher risk of adverse COVID-19
outcomes (as defined by Public Health England - see Appendix
IA) based on data from the baseline survey; health or care worker
status; and inclusion within one of the UK Joint Committee on Vac-
cination and Immunisation (JCVI)’s priority groups for COVID-19
vaccination (see Appendix IA) [20]. Data on exposure variables
were collected through the baseline survey completed on entry
into the Virus Watch study.
2.4. Outcomes
The primary outcome of interest was each participant’s
response to the following question: ‘Would you accept a COVID-19
vaccine if offered?’. Outcome data were collected over two separate
time periods (1–14 December 2020 and 17–28 Feb 2021) through
surveys sent to the whole Virus Watch cohort on the first listed
day. Possible responses were: ‘Yes’, ‘No’, ‘Unsure’ and ‘Already had
a COVID-19 vaccine’ (February survey only).
Between 4th-11th January 2021, psychological influences on
vaccination intention were surveyed using a 13-item questionnaire
measuring attitudes, beliefs and emotions related to COVID-19 ill-
ness and vaccination. This questionnaire was adapted from a 16-
item measure used in the Flu Watch cohort study to measure
vaccination-related attitudes during the H1N1 influenza pandemic
[15]; three items were removed, and the wording of the remaining
items adapted to reflect the current pandemic situation. Partici-
pants rated their agreement for all items on a 5-point Likert scale
(‘strongly disagree’ – ‘strongly agree’), with negative-worded items
reverse coded prior to analysis. The full questionnaire is provided
in Appendix II.
2.5. Statistical analysis
Baseline and monthly survey response data were extracted
from REDCap, linked, and analysed in Stata (version 16.0, Stata-
Corp). Observations missing data on the primary outcome of inter-
est were excluded from the denominators of all analyses.
Respondents with missing baseline information were excluded
from only the relevant explanatory variable denominator; for
example, those missing a postcode were excluded from analyses
by region and IMD.
To examine changes in intention over time, responses to the
February survey were compared to those from December among
individuals with complete data at both time points. We grouped
‘No’ and ‘Unsure’ responses due to small numbers. The percentage
change in response was calculated overall and by ethnicity and
IMD quintile. We suppressed low cell counts across certain cate-
gories to reduce the possibility of deductive disclosure.
We used multinomial logistic regression to derive relative odds
ratios and 95% confidence intervals for the association between a
range of demographic, social, and clinical participant characteris-
tics and responses to the question ‘Would you accept a COVID-19
vaccine if offered?’ among participants who responded to both
the December 2020 and February 2021 surveys. We first tested
the association for each variable separately, adjusting only for
age and sex (a priori variables). Variables that were significantly
associated in univariable analyses and considered theoretically rel-
evant to vaccine intention were included in the fully-adjusted mul-
tivariable models (‘‘Unsure” vs ‘‘Yes” and ‘‘No” vs ‘‘Yes” in
December 2020 and ‘‘Unsure” vs ‘‘Yes or Already had a vaccine”
and ‘‘No” versus ‘‘Yes or Already had a vaccine” in February
2021). The multivariable models also included a random term to
account for clustering at the household level.7110To identify psychological influences on vaccination intention,
survey responses from the January monthly survey were split into
a ‘training’ dataset (n = 10,088 responses) for exploratory factor
analysis and a ‘cross-validation’ dataset (n = 10,890) for confirma-
tory factor analysis. Further details of the approach are in Appendix
III. To assess whether psychological factors differed by socio-
demographic characteristics, we compared median factor scores
based on their exact 95% confidence intervals and Kruskall-Wallis
equality of populations rank tests by age group, sex, IMD quintile,
and ethnicity among a subset of participants who responded to all
three surveys (December, January and February n = 11,623).
2.6. Ethics
This study was approved by the Hampstead NHS Health
Research Authority Ethics Committee. Ethics approval number 
20/HRA/2320.
2.7. Patient and public involvement
The study team worked with the Race Equality Foundation and
Doctors of the World who advised on the inclusion of people from
minority ethnic backgrounds in Virus Watch and set up a commu-
nity advisory group to inform the ongoing design and dissemina-
tion of health equity aspects of Virus Watch. This advisory group,
consisting of lay members of the public, community leaders, char-
ities and policy experts, guided and reviewed the analyses
described in this paper. Results of this and other Virus Watch anal-
yses are disseminated to participants via the http://ucl-virus-
watch.net/ website.
3. Results
When data were extracted on 28 February 2021, there were
22,556 households and 46,539 people taking part in Virus Watch
across England and Wales, of whom 40,810 (88%) were adults aged
16 years and over and 4,858 (12%) people from minority ethnic
backgrounds (Table 1).
3.1. Trends in vaccination intention
Participants responded to the survey question ‘‘Would you
accept a COVID-19 vaccine if offered?”. The response rate for par-
ticipants aged 16 or over to the bespoke monthly survey in Decem-
ber 2020 was 56% (20,785/36,998) and in February 2021 was 53%
(20,590/38,727), with 14,880 adults reporting across both time
points. Table 1 summarises the characteristics of people who
answered these surveys.
In December 2020, 18,508 (89%) participants responded ‘‘Yes”;
1,814 (9%) said they were ‘‘Unsure”; and 463 (2%) responded
‘‘No”. In February 2021, 7,847 (38%) participants responded
‘‘Already had a COVID-19 vaccine”; 12,273 (60%) responded ‘‘Yes”;
288 (1%) said they were ‘‘Unsure”; and 182 (1%) responded ‘‘No”
(see Appendix IB for full description of responses by explanatory
variables).
Examining only participants who answered the survey question
at both timepoints, 13,411 responded ‘‘Yes” in December 2020. Of
these, 13,322 (99%) went on to respond ‘‘Yes” or ‘‘Already had a
COVID-19 vaccine” and 89 (1%) to respond ‘‘No” or ‘‘Unsure” in
February 2021 (Table 2).
Again, examining only participants who answered the survey
question at both timepoints, 1,469 responded ‘‘No” or ‘‘Unsure”
in December 2020. Of these, 1,266 (86%) went on to respond ‘‘Yes”
Table 1
Characteristics of adult Virus Watch study participants who responded to the
question on COVID-19 vaccine intention in December 2020 and again in February
2021.
Adults responding to both















Born in UK 11,932 80.2
Born abroad 1,134 7.6
Missing 1,814 12.2
Ethnicity
White British 13,220 88.8
White Irish 202 1.4
White Other 610 4.1
South Asian 251 1.7
Other Asian 100 0.7
Black 43 0.3
Mixed 143 1.0
Other ethnicity 52 0.4
Prefer not to disclose or missing 259 1.7
Region
East Midlands 1,398 9.4
East of England 2,975 20.0
London 1,490 10.0
North East 729 4.9
North West 1,603 10.8
South East 2,534 17.0
South West 1,204 8.1
West Midlands 845 5.7








5 (least deprived) 5,072 34.1
Missing 1,005 6.8
Health or care worker status 558 3.8
Priority health condition 6,241 42.0
JCVI priority groups
Group 2 926 6.2
Group 3 890 6.0
Group 4 2,849 19.2
Group 5 2,455 16.5
Group 6 2,396 16.1
Group 7 1,156 7.8
Group 8 915 6.2
Group 9 672 4.5
Not in any JCVI priority group 2,621 17.6
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responded ‘‘No” or ‘‘Unsure” once again in February 2021. The
magnitude of this shift in intention to accept a COVID-19 vaccine
was high across all ethnic groups measured ranging from 70% in
people from the Other Asian ethnic background to 91% in people
from South Asian ethnic backgrounds (Table 2). It was also high
across all age groups (ranging from 74% in 16–24 year-olds to
97% in over 75 year-olds) IMD quintiles (ranging from 80% to
89%), and regions (ranging from 81% in London to 97% in Wales).71113.2. Factors associated with uncertainty or intention to refuse
vaccination
Sex at birth, age group, ethnicity, IMD quintile and having a pri-
ority health condition were included in all fully-adjusted multi-
variable regression models (Fig. 1). In the final models, age was
most strongly associated with vaccination intention in both mod-
els, with intention to accept a COVID-19 vaccine inversely related
to age. In December 2020, 16–24 year-olds were more likely to
say Unsure and No versus ‘Yes’ compared to 65–74 year-olds
(‘Unsure’: OR 4.63, 95 %CI 3.42, 6.27, p < 0.001; ‘No’: OR 7.17,
95 %CI 4.26, 12.07, p < 0.001). In February 2021, relative disparities
between age groups had widened, with 16–24 year-olds much
more likely to say ‘Unsure’ and ‘No’ compared to 65–74 year-olds
(‘Unsure’: OR 27.92, 95 %CI 13.79, 56.51, p < 0.001; ‘No’: OR
17.16, 95 %CI 4.12, 71.55, p < 0.001).
In December 2020, females were more likely to respond
‘Unsure’ compared to males (OR 1.19, 95% CI 1.08, 1.32
p < 0.001) but the odds of responding ‘No’ were not found to be
associated with sex and there was no significant difference by
sex observed in February 2021. People with a health condition that
was prioritised for COVID-19 vaccination (as defined by Public
Health England - see Appendix IA) were less likely to respond
‘No’ compared to those without a priority health condition in
December 2020 (OR 0.6495% CI 0.48, 0.87, p = 0.004).
In December 2020, ethnicity was associated with vaccine inten-
tion after adjustment for all other explanatory variables. People
from White Other (‘Unsure’: OR 1.57., 95 %CI 1.18, 2.10,
p = 0.002; ‘No’: OR 1.97, 95 %CI 1.17, 3.31, p = 0.011), Black
(‘Unsure’: OR 3.31, 95 %CI 1.32, 8.26, p = 0.010; ‘No’: OR 5.49,
95 %CI 1.74, 17.27, p = 0.004), and Other (‘Unsure’: OR 4.10, 95 %
CI 1.99, 8.46, p < 0.001; ‘No’: OR 5.51, 95 %CI 1.95, 15.52,
p = 0.001) ethnic backgrounds were more likely to say ‘No’ and
‘Unsure’ versus ‘Yes’ compared with those from White British
backgrounds. In February 2021, this association was weaker and
disparities in vaccine intention between ethnic groups were
reduced. Only people from Other ethnic backgrounds (OR 5.36,
95 %CI 1.26, 22.92, p = 0.023) remained more likely to say ‘No’ com-
pared to White British people, and only people from White Other
ethnic backgrounds (OR 2.03, 95 %CI 1.13, 3.66, p = 0.018)
remained more likely to say ‘Unsure’ compared to White British
people.
Across both time points, there was a gradient in vaccine inten-
tion by local area deprivation. In December 2020, people living in
the two most deprived quintiles (IMD = 1 and IMD = 2) were more
likely to say ‘Unsure’ and people living in the three most deprived
quintiles (IMD = 1 and IMD = 2 and IMD3) were more likely to say
‘No’ compared to those living in the least deprived quintile
(IMD = 5). In February 2021, those from IMD = 1 and IMD = 2 were
more likely to say ‘Unsure’ (OR 2.51, 95 %CI 1.17, 5.37, p = 0.018 &
OR 1.97, 95 %CI 1.07, 3.60, p = 0.028) and people from areas in
IMD = 3 were also more likely to answer ‘No’ (OR 2.20, 95 %CI
1.04, 4.65, p = 0.038) compared to those living in least deprived
quintile.
3.3. Psychological influences on vaccination intention
Exploratory factor analysis (EFA) of responses to the 13-item
questionnaire suggested a two-factor structure. Factor 1 comprises
beliefs and concerns around the efficacy, safety, side-effects, and
time burden of vaccination and is made up of eight questions
(items 6–13 in questionnaire, see supplementary materials), e.g.
‘‘I am concerned that the COVID-19 vaccine will not have been
tested enough”. Factor 2 comprises risk perception and concern
around acquiring, transmitting, and suffering severe effects of
COVID-19 and is made up of four questions (items 1–4 in question-
Table 2
Change in responses to ‘‘Would you accept a COVID-19 vaccine if offered” from December to February, by ethnicity and IMD quintile (n = 14,880).
‘‘Yes” in Dec 2020
N = 13,411 (90%) when asked again in Feb 2021
‘‘No or Unsure” in Dec 2020
N = 1,469 (10%) when asked again in Feb 2021
Yes or Already had
N = 13,322 (99%)
No or Unsure
N = 89 (1%)
Yes or Already had
N = 1,266 (86%)
No or Unsure
N = 203 (14%)
Age (years)
16–24 580 (97%) 20 (3%) 124 (74%) 44 (26%)
25–34 654 (97%) 21 (3%) 118 (77%) 35 (23%)
35–44 1,013 (99%) 11 (1%) 189 (84%) 36 (16%)
45–54 1,689 (99%) 14 (1%) 249 (84%) 48 (16%)
55–64 3,416 (100%) 15 (0%) 302 (92%) 26 (8%)
65–74 4,772 (100%) 5 (0%) 224 (95%) 12 (5%)
75+ 1,198 (100%) 3 (0%) 60 (97%) 2 (3%)
Ethnicity category (n = 12,902)
White British 11,972 (99%) 71 (1%) 1,028 (87%) 149 (13%)
White Irish 173 (98%) 3 (2%) 22 (85%) 4 (15%)
White Other 489 (99%) 3 (1%) 94 (80%) 24 (20%)
South Asian 214 (99%) 3 (1%) 31 (91%) 3 (9%)
Other Asian 79 (99%) 1 (1%) 14 (70%) 6 (30%)
Black 26 (96%) 1 (4%) 14 (88%) 2 (13%)
Mixed 115 (97%) 4 (3%) 19 (79%) 5 (21%)
Other Ethnicity 35 (100%) 0 (0%) 14 (82%) 3 (18%)
IMD Quintile (n = 13,715)
1 (Most deprived) 548 (99%) 4 (1%) 78 (83%) 16 (17%)
2 1,187 (99%) 8 (1%) 171 (80%) 43 (20%)
3 2,371 (99%) 20 (1%) 231 (86%) 39 (14%)
4 3,691 (99%) 21 (1%) 326 (87%) 49 (13%)
5 (Least deprived) 4,640 (99%) 24 (1%) 365 (89%) 43 (11%)
Region (n = 13,875)
East Midlands 1,258 (99%) 8 (1%) 118 (89%) 14 (11%)
East of England 2,671 (99%) 17 (1%) 253 (88%) 34 (12%)
London 1,250 (99%) 12 (1%) 185 (81%) 43 (19%)
North East 656 (99%) 7 (1%) 57 (86%) 9 (14%)
North West 1,414 (99%) 13 (1%) 142 (81%) 34 (19%)
South East 2,323 (100%) 6 (0%) 177 (86%) 28 (14%)
South West 1,110 (100%) 5 (0%) 84 (94%) 5 (6%)
West Midlands 762 (99%) 7 (1%) 67 (88%) 9 (12%)
Yorkshire and The Humber 702 (100%) 0 (0%) 60 (82%) 13 (18%)
Wales 291 (99%) 2 (1%) 28 (97%) 1 (3%)
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item (item 5: ‘‘worry about time off work/education due to COVID-
19”) was removed during EFA due to improved scale reliability
after removal (Cronbach’s a 0.75 vs 0.78), and low communality
and factor loadings. This item was considered theoretically rele-
vant and retained as an individual item in later analyses. Removal
of this item did not substantially affect the EFA results. All indices
of relative and absolute fit based on confirmatory factor analysis
(CFA) indicated that the two-factor EFA model was the best fit to
the data, compared to univariable models including or excluding
Item 5. Detailed EFA results pre- and post-removal and CFA results
including factor loadings and indices of relative and absolute fit are
reported in Appendix III.
Factors 1 and 2 were found to consistently predict responding
‘‘Unsure” or ‘‘No” versus ‘‘Yes” when participants were asked about
their vaccination intention (Table 3). The first factor, relating to
COVID-19 vaccines, demonstrated the strongest association with
being unsure about vaccination (December OR: 0.23 [0.20, 0.26];
February OR: 0.20 [0.17, 0.24]) and intended refusal (December
OR: 0.15 [0.12, 0.20]; February OR: 0.24 [0.18, 0.32]). The second
factor, relating to COVID-19 illness, was also predictive of being
unsure (December OR: 0.59 [0.54, 0.65]; February OR: 0.33 [0.28,
0.40]) and intended refusal (December OR: 0.38 [0.32, 0.46]; Febru-
ary OR: 0.45 [0.34, 0.61]). Worries about missing work or educa-
tion due to COVID-19 (item 5), for which analyses were limited
to participants who reported being in work or education, were
associated with an increased risk of being unsure about taking a
COVID-19 vaccine (OR:1.11 [1.03, 1.19]), but not intended refusal
(OR: 1.09 [0.94, 1.27]) in December only.7112Both psychological factors varied by age (Table 4), with more
positive vaccination-related attitudes and greater concern about
COVID-19 illness in older age groups, based on Factors 1 and 2
(e.g., for both factors, median for 16–24 years: 4, 95% CI: 4,4;
75 + years: 5 95% CI: 5, 5). White British participants had higher
median scores (5, 95% CI: 5, 5) for Factor 1, indicating more positive
views about COVID-19 vaccines compared to participants from
several minority ethnic minority groups, including participants
identifying as Black (4, 95 %CI: 3.5, 4), South Asian (4, 95 %CI: 4,
4.5), Other Asian (4, 95 %CI: 4, 4.5), White Other (4.5, 95 %CI: 4.5,
4.5), and Other Ethnicity (4, 95 %CI: 4, 4.93). Perceptions and con-
cerns about COVID-19 illness did not differ by ethnicity.
4. Discussion
In this study of over 20,000 adults from the Virus Watch cohort,
the number of people who intended to accept, or had already
accepted, a COVID-19 vaccine when offered increased from 89%
in December 2020 to 98% in February 2021. Over four in five adults
(86%) who were uncertain or intending to refuse a COVID-19 vac-
cine in December 2020 had changed their mind and planned on
accepting, or had already accepted, a vaccine in February 2021.
This shift was observed at a similar magnitude across all ethnic
groups measured, all levels of social deprivation and all age groups.
Despite this shift, disparities in vaccine intention still exist. Young
adults and people from White Other and Other ethnic backgrounds
were more likely to intend to refuse or be unsure about taking a
COVID-19 vaccine relative to older adults and White British people
respectively.
Fig. 1. Odds ratio estimates and 95% confidence intervals from multinomial multivariable logistic regression models exploring factors associated with intention to accept a
COVID-19 vaccine (‘Unsure’ vs ‘Yes’ and ‘No’ vs ‘Yes’) in December 2020 and February 2021 (see tables in Appendix IB, IC).
Table 3
Odds Ratios between Psychological Factors and COVID-19 Vaccine Intention among participants who responded to all three surveys (n = 11,623).
Odds Ratio [95% CI]
December February
Unsure vs Yes No vs Yes Unsure vs Yes No vs Yes
























*limited to participants in work/education at baseline (n = 4,595).
T. Byrne, P. Patel, M. Shrotri et al. Vaccine 39 (2021) 7108–7116Concerns about COVID-19 vaccines and concerns about COVID-
19 illness predicted intention to take a vaccine. Older adults were
the least likely to have concerns about the vaccine and most likely
to have concerns about COVID-19. White British people had fewer
concerns about COVID-19 vaccines than people from most minor-
ity ethnic groups, but there were no differences between ethnic
groups regarding concerns about contracting and/or becoming
unwell with COVID-19 illness.
Our cohort analysis of trends in vaccine intention provides evi-
dence that many individuals have changed their minds to become
pro-vaccine. This supports cross-sectional surveys that have found
COVID-19 vaccination intention has increased over time in the UK
[5,21,22]. Previous studies have found age, ethnicity and social
deprivation are independently associated with intention to take a
COVID-19 vaccine [9,10]. This study confirms that younger adults
are more likely to be unsure or intend to refuse a COVID-19 vaccine
compared to older adults. We find the association between ethnic-7113ity and vaccine intention has weakened. In February 2021, only
people from Other ethnic backgrounds were more likely to refuse,
and only people from White Other ethnic groups were more likely
to be unsure about taking a COVID-19 vaccine compared to White
British people. This is a substantial change from December 2021
and differs from existing evidence on ethnic disparities in COVID-
19 vaccine intention [9,10]. Similarly, the relationship between
deprivation and vaccine intention (where more deprived groups
were associated with lower levels of intention to be vaccinated)
has weakened but not disappeared.
It is possible that public health communications to promote
vaccination uptake and participatory community engagement,
such as using places of worship as vaccination centres, have con-
tributed to this shift. It is also possible that growing numbers of
people being vaccinated during the period of this study has con-
tributed to the change in intention through network effects and
anticipated regret. It is especially encouraging that the intention
Table 4
Median Factor Scores, 95% Confidence Intervals and Kruskal-Wallis equality of populations rank test p-values by Socio-Demographic Characteristics (n = 11,623).
Factor 1






‘I was worried about having to
take time off work/education
because of COVID-190*
Median [95% CI] p-value Median [95% CI] p-value Median [95% CI] p-value
Age Group 16–24 4 (4–4) <0.001 4 (4, 4) <0.001 4 (3, 4) <0.001
25–34 4.5 (4.5–4.5) 4 (4, 4) 3 (3, 3)
35–44 4.5 (4, 4.5) 4 (4, 4) 3 (3, 3)
45–54 4.5 (4.5, 4.5) 4.5 (4.5, 4.5) 3 (3, 3)
55–64 5 (5, 5) 4.5 (4.5, 4.5) 3 (3, 3)
65–74 5 (5,5) 5 (5, 5) 2 (2, 3)
75+ 5 (5, 5) 5 (5, 5) 2 (2, 3)
Sex Male 5 (4.5, 5) 0.190 4.5 (4.5, 4.5) 0.004 3 (3, 3) 0.381
Female 5 (5, 5) 4.5 (4.5, 4.5) 3 (3, 3)
Ethnicity White British 5 (5, 5) <0.001 4.5 (4.5, 4.5) 0.002 3 (3, 3) 0.128
White Irish 5 (4.5, 5) 4.5 (4.5, 5) 3 (2, 4)
White Other 4.5 (4.5, 4.5) 4.5 (4.5, 4.5) 3 (3, 3)
South Asian 4 (4, 4.5) 4.5 (4.5, 5) 3 (3, 4)
Other Asian 4 (4, 4.5) 4.5 (4, 4.5) 3 (3, 4)
Black 4 (3.5, 4) 4.5 (4, 5) 2 (1.33,3)
Mixed 4.5 (4, 5) 4.5 (4, 4.5) 3 (2, 4)
Other Ethnicity 4 (4, 4.93) 5 (4, 5) 3 (2.13,4)
IMD 1 (Most deprived) 4.5 (4.5, 5) <0.001 4.5 (4.5, 4.5) 0.440 3 (3, 3) 0.009
2 4.5 (4.5, 5) 4.5 (4.5, 4.5) 3 (3, 3)
3 5 (4.5, 5) 4.5 (4.5, 4.5) 3 (3, 3)
4 5 (4.5, 5) 4.5 (4.5, 4.5) 3 (3, 3)
5 (Least deprived) 5 (5, 5) 4.5 (4.5, 4.5) 3 (3, 3)
*Limited to participants in work/education at baseline.
T. Byrne, P. Patel, M. Shrotri et al. Vaccine 39 (2021) 7108–7116to accept a COVID-19 vaccine has increased across all age, ethnic
and social deprivation groups. Repeating offers of a COVID-19 vac-
cine to people may be important as large numbers of people have
changed their minds over the course of a few months. Our findings
also suggest that communications focusing on COVID-19 vaccine
safety and effectiveness may be more effective than those focusing
on COVID-19 illness risk and perception.
Despite the pro-vaccine shift observed and the narrowing of
ethnic disparities in vaccine intention, disparities in vaccination
rates between ethnic groups remain wide [23]. It suggests differ-
ences in vaccine intention may not be the only cause of ethnic dis-
parities in vaccination rates and that barriers to vaccine access may
also be contributing. A recent analysis of survey data from 1.4 mil-
lion adults aged over 55 found people from most minority ethnic
backgrounds were more likely to report difficulty walking and dif-
ficulty performing usual activities compared to White British peo-
ple [24]. The Department for Transport’s national statistics from
2019 shows 39 per cent of Black adults live in households without
a car compared to 17 per cent of White adults [25]. An analysis of
survey data from the UK Household Longitudinal Survey found
Black adults and Asian adults over the age of 65 are both around
twice as likely to report having no close friends and no friends
who live locally [26]. Each of these are potential structural barriers
to vaccine access that may be contributing to lower vaccination
rates in minority ethnic groups. Door-to-door vaccines, which have
been piloted in some parts of the UK, may be effective at increasing
vaccination rates and reducing ethnic disparities.
In our separate analysis of psychological influences on vaccine
intention, beliefs and concerns about COVID-19 vaccines were
strongly associated with intended vaccine uptake. This is in keep-
ing with research conducted prior to the UK COVID-19 vaccination
programme commencing which found beliefs around the efficacy,
development, risks and importance of COVID-19 vaccines strongly
predicted intention to accept a vaccine [15]. This study also finds
beliefs and concerns around COVID-19 illness consistently predict
vaccination intention. Our analysis was not able to consider struc-7114tural reasons that determine vaccination intention beyond the role
of missing work and education. Specifically, we did not measure
conspiratorial beliefs and views of healthcare and medicine or trust
in the government which have been previously found to affect vac-
cination intention [27]. We also did not collect data on how vaccine
intention was affected by vaccine characteristics (including brand
of vaccine, protection duration, location of manufacture and
approval status), which have been shown to be associated with
vaccine acceptance [28,29].4.1. Strengths and limitations
Virus Watch is a national household community cohort study.
Individuals in the study were geographically distributed across
England and Wales and the cohort was diverse in terms of age,
sex, ethnicity, and socio-economic composition. This is a large
cohort study of vaccination intention in England and Wales and
has a large number of participants from minority ethnic back-
grounds. However, given participation in the Virus Watch study
is voluntary and sampling non-random, the cohort is likely biased
toward people concerned about COVID-19 and participants were
more likely to be White British, over the age of 65 and have a
higher income than the general population. As a result, the data
presented in this paper likely overestimate the degree of vaccine
intention in England and Wales between December 2020 and
February 2021 as people from minority ethnic backgrounds,
younger people and those living in more deprived areas are more
likely to be vaccine hesitant, due to structural differences in access
to and participation in healthcare and medical research [30–32].
Our multivariable regression analyses adjust for age, ethnicity
and IMDwhich should reduce this bias, however, any bias resulting
from residual confounding means that our results are likely overes-
timates of the true magnitude of the association.
Despite the cohort size, samples were too small to disaggregate
ethnic groups into more granular categories. Guided by our com-
munity advisory board, participants who expressed uncertainty
T. Byrne, P. Patel, M. Shrotri et al. Vaccine 39 (2021) 7108–7116were separated from participants intending to refuse COVID-19
vaccines in our analysis of factors associated with vaccine inten-
tion, as it was felt that these groups characterise different popula-
tions. Sample sizes precluded this separation in our analyses of
temporal trends and psychological influences on vaccine intention.
Another important limitation is that only households with at least
one member able to read English language and access mobile or
broadband internet were able to take part in the study. Guided
by our community advisory board, Virus Watch study surveys have
since been translated into 9 languages to allow non-English speak-
ers to participate.
4.2. Conclusions
The considerable increase in intention to accept a COVID-19
vaccine across all ethnic and social groups when offered observed
in this study is encouraging.
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